Tom DiMaggio

721 total citations
6 papers, 259 citations indexed

About

Tom DiMaggio is a scholar working on Immunology and Allergy, Infectious Diseases and Oncology. According to data from OpenAlex, Tom DiMaggio has authored 6 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Immunology and Allergy, 2 papers in Infectious Diseases and 2 papers in Oncology. Recurrent topics in Tom DiMaggio's work include Food Allergy and Anaphylaxis Research (3 papers), Transgenic Plants and Applications (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Tom DiMaggio is often cited by papers focused on Food Allergy and Anaphylaxis Research (3 papers), Transgenic Plants and Applications (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Tom DiMaggio collaborates with scholars based in United States, Australia and Italy. Tom DiMaggio's co-authors include Joshua D. Milner, Hirsh D. Komarow, Michael P. O’Connell, Roberta Zanotti, Peter Korošec, Yun Bai, Yihui Liu, Ji-Won Kim, Lawrence B. Schwartz and Jonathan J. Lyons and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Frontiers in Immunology and RMD Open.

In The Last Decade

Tom DiMaggio

6 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom DiMaggio United States 5 171 139 64 53 39 6 259
Yulia Dorofeeva Austria 6 52 0.3× 121 0.9× 66 1.0× 24 0.5× 45 1.2× 8 185
Theo Gülen Sweden 15 535 3.1× 443 3.2× 125 2.0× 226 4.3× 34 0.9× 34 652
Thomas DiMaggio United States 5 89 0.5× 49 0.4× 36 0.6× 19 0.4× 10 0.3× 9 134
Harald Kurz Austria 6 124 0.7× 62 0.4× 44 0.7× 16 0.3× 106 2.7× 7 276
Celeste Nelson United States 3 93 0.5× 30 0.2× 26 0.4× 21 0.4× 27 0.7× 4 124
John Jung United States 5 68 0.4× 131 0.9× 53 0.8× 32 0.6× 181 4.6× 7 283
Étienne Saint‐Cyr Proulx Canada 8 117 0.7× 221 1.6× 112 1.8× 65 1.2× 333 8.5× 16 413
Nina Jones United States 2 109 0.6× 44 0.3× 36 0.6× 18 0.3× 18 0.5× 2 144
Ruediger Hein Germany 5 112 0.7× 62 0.4× 60 0.9× 39 0.7× 158 4.1× 5 231
Naoko Hosomi Japan 8 32 0.2× 97 0.7× 44 0.7× 15 0.3× 122 3.1× 11 276

Countries citing papers authored by Tom DiMaggio

Since Specialization
Citations

This map shows the geographic impact of Tom DiMaggio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom DiMaggio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom DiMaggio more than expected).

Fields of papers citing papers by Tom DiMaggio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom DiMaggio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom DiMaggio. The network helps show where Tom DiMaggio may publish in the future.

Co-authorship network of co-authors of Tom DiMaggio

This figure shows the co-authorship network connecting the top 25 collaborators of Tom DiMaggio. A scholar is included among the top collaborators of Tom DiMaggio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom DiMaggio. Tom DiMaggio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Thomas, Κonstantinos, Aggelos Banos, Julie E. Niemela, et al.. (2023). NF-kappa-B essential modulator (NEMO) gene polymorphism in an adult woman with systemic lupus erythematosus and recurrent non-tuberculous mycobacterial disseminated infections. RMD Open. 9(2). e003149–e003149. 1 indexed citations
2.
Ferré, Elise M. N., Monica M. Schmitt, Sebastian Ochoa, et al.. (2021). SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients. Frontiers in Immunology. 12. 720205–720205. 13 indexed citations
3.
Lyons, Jonathan J., Jack Chovanec, Michael P. O’Connell, et al.. (2020). Heritable risk for severe anaphylaxis associated with increased α-tryptase–encoding germline copy number at TPSAB1. Journal of Allergy and Clinical Immunology. 147(2). 622–632. 144 indexed citations
4.
Peled, A., Ofer Sarig, Guangping Sun, et al.. (2018). Loss-of-function mutations in caspase recruitment domain-containing protein 14 (CARD14) are associated with a severe variant of atopic dermatitis. Journal of Allergy and Clinical Immunology. 143(1). 173–181.e10. 52 indexed citations
5.
Weissler, Katherine A., Tom DiMaggio, Daly Cantave, et al.. (2018). Identification and analysis of peanut-specific effector T and regulatory T cells in children allergic and tolerant to peanut. Journal of Allergy and Clinical Immunology. 141(5). 1699–1710.e7. 38 indexed citations
6.
Zhang, Yuan, Andrea Siegel, Guangping Sun, et al.. (2018). Human TH9 differentiation is dependent on signal transducer and activator of transcription (STAT) 3 to restrain STAT1-mediated inhibition. Journal of Allergy and Clinical Immunology. 143(3). 1108–1118.e4. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026